Google News – Pharmaceuticals External News
Regulatory & Compliance Articles
Google News – Clinical Trials External News
Biohaven’s epilepsy drug hit with FDA clinical hold - Clinical Trials Arena
Google News – Pharmaceuticals External News
Olema Pharmaceuticals, Inc. $OLMA Shares Sold by Squarepoint Ops LLC - MarketBeat
Industry News External News
Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observations - BusinessLine
Google News – Clinical Trials External News
In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy - Fierce Pharma
Google News – Clinical Trials External News
FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer - The Clinical Trial Vanguard
Google News – Biopharma External News
GC Biopharma wins approval for phase 2 Covid-19 mRNA vaccine trial - Korea Biomedical Review
Google News – Biopharma External News
FDA partially halts trials of SK Biopharmaceuticals’ epilepsy drug candidate - Korea JoongAng Daily
Google News – Medical Devices External News
Nutromics receives FDA Breakthrough Device Designation - Business Wire
Google News – FDA (biotech/pharma) External News
SK biopharmaceuticals says $400 mil. opakalim payment awaits FDA hold resolution - Korea Biomedical Review
Google News – FDA (biotech/pharma) External News
Friday Five – Novartis' stumbles spark boardroom backlash, Nodthera name drops, FDA throws wrench into Biohaven deal…and more - FirstWord Pharma
Google News – Clinical Trials External News
FDA Clears CU Anschutz Clinical Trial Using Engineered Immune Cells to Fight Colorectal Cancer - PR Newswire
Google News – FDA (biotech/pharma) External News
FDA expands indication for Bayer’s Hyrnuo - The Pharma Letter
Google News – Clinical Trials External News
Strengthening female participation in clinical trials with AI-driven eConsent - europeanpharmaceuticalreview.com
Google News – FDA (biotech/pharma) External News